Background: Pulmonary arterial hypertension (PAH) is characterized by elevated pulmonary artery pressure and vascular resistance, leading to systemic venous hypertension and potential right heart ...

Other eye involved in 15% of cases at 5 years Abbreviations: AION, anterior ischemic optic neuropathy; BRAO, branch retinal artery occlusion; CWS, cotton-wool spots; ESR, erythrocyte sedimentation ...

AION is the most common cause of visual loss in giant cell arteritis. [6] In AION, the presence of cotton-wool spots separately from the optic disk is almost pathognomonic of arteritic AION.

Diagnosis. Susac syndrome, characterized by a combination of encephalopathy, branch retinal artery occlusions, and hearing loss. Management. Long-term immunosuppressive treatment with azathioprine ...

2 However, in our case, the most obvious ST elevation was at lead I and avL. ST elevation in leads I and aVL usually indicated ischaemia at anterolateral territory, with the occlusion of left anterior ...

601A anti-VEGF Ab is under clinical development by Sunshine Guojian Pharmaceutical Shanghai and currently in Phase III for Branch Retinal Vein Occlusion. According to GlobalData, Phase III drugs for ...

QUASAR is a global, double-masked, active-controlled phase 3 trial evaluating the efficacy and safety of EYLEA HD, compared to EYLEA, in patients with retinal vein occlusion (RVO), including those ...

amc.uva.nl Introduction Acute ischemic stroke (AIS) due to internal carotid artery (ICA) occlusion has a poor prognosis if treated by intravenous thrombolysis. Intra-arterial (IA) treatment is a ...

tum.de Background In stroke due to middle cerebral artery (MCA) occlusion, collaterals may sustain tissue in the peripheral MCA territory, extending the time window for recanalizing therapies. However ...

korea.ac.kr Background/aims To identify risk factors of recurrence of macular oedema in branch retinal vein occlusion (BRVO) after intravitreal bevacizumab (IVB) injection. Methods The records of 63 ...

Objective: To provide more data on the outcome of conventional treatment. Methods: Data were analysed on patients from three centres with symptomatic basilar artery occlusion treated conventionally.